Here are four things to know:
1. Matthew Jewett is the company’s CEO and will serve on the board of directors, effective June 26.
2. Mr. Jewett has extensive experience in the medical device industry, previously holding various executive positions at DePuy Synthes.
3. He will lead Conventus as they try to establish Cage technology as the standard of care for extremity fracture treatment.
4. The Cage technology is designed to boost patient outcomes, improve surgeon experience and offer economic value.
More articles on devices:
Vertebral compression fracture devices market to reach $1.1M by 2022: 5 insights
Mazor Robotics, Stryker, K2M & more: 19 device company key notes
Global orthopedic devices market set to reach $49.1B by 2021: 7 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
